Skip to main content

Table 1 The baseline clinical characteristics

From: Susceptible gene polymorphism in patients with three-vessel coronary artery disease

 

MACCE group (n = 342)

Non-CAD group (n = 344)

P-value

Age, year

62.8 ± 10.2

50.5 ± 11.5

< 0.0001

Male, %

270 (78.9)

198 (57.6)

< 0.0001

BMI, kg/m2

25.7 ± 3.2

25.3 ± 3.1

0.147

Hypertension, %

241 (70.5)

44 (12.8)

< 0.0001

DM, %

134 (39.2)

14 (4.1)

< 0.0001

Hyperlipidemia, %

209 (61.1)

25 (7.3)

< 0.0001

Stroke, %

56 (16.4)

1 (0.3)

< 0.0001

PVD, %

31 (9.1)

0 (0.0)

< 0.0001

Smoking history, %

201 (58.8)

64 (18.6)

< 0.0001

WBC, *109/L

7.21 ± 2.08

6.25 ± 1.73

< 0.0001

Hemoglobin, g/L

136.7 ± 14.9

144.9 ± 12.3

< 0.0001

ALT, IU/L

30.2 ± 22.6

24.2 ± 16.0

< 0.0001

Serum creatinine, μmol/L

84.5 ± 22.0

72.6 ± 18.4

< 0.0001

Uric acid, μmol/L

322.1 ± 88.3

332.4 ± 98.2

0.151

Triglyceride, mmol/L

1.77 ± 0.94

1.72 ± 1.19

0.533

Total cholesterol, mmol/L

4.61 ± 1.07

4.68 ± 1.15

0.389

HDL-C, mmol/L

1.05 ± 0.24

1.15 ± 0.32

< 0.0001

LDL-C, mmol/L

2.56 ± 0.81

2.87 ± 0.88

< 0.0001

FPG, mmol/L

6.31 ± 2.32

5.61 ± 1.23

< 0.0001

CK-MB, IU/L

19.4 ± 40.9

14.9 ± 4.5

0.046

Hs-CRP, mg/L

3.77 ± 3.62

2.23 ± 1.57

< 0.0001

  1. ALT alanine transaminase, BMI, body mass index, CAD coronary artery disease, CK-MB creatine kinase-muscle/brain, DM diabetes mellitus, FPG fasting plasma glucose, HDL-C High-density lipoprotein cholesterol, Hs-CRP High-sensitivity C-reactive protein, LDL-C Low-density lipoprotein cholesterol, MACCE major adverse cardiovascular and cerebrovascular events, PVD peripheral vessel disease, WBC white blood cell count